Mavodelpar (REN001) is a selective PPARdelta agonist. Mavodelpar suppresses glomerular injury and renal fibrosis. Mavodelpar can be used for the research of primary mitochondrial myopathies (PMM) and long-chain fatty acid oxidation disorders (LC-FAOD)[1]. Ma
Molecular Weight:
537.55
Purity:
99.89
CAS Number:
[1604815-32-8]
Formula:
C31H29FNNaO5
Target:
PPAR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted